These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
379 related articles for article (PubMed ID: 14580261)
1. Quantitative determination, by real-time reverse transcription polymerase chain reaction, of aromatase mRNA in invasive ductal carcinoma of the breast. Zhang Z; Yamashita H; Toyama T; Omoto Y; Sugiura H; Hara Y; Wu X; Kobayashi S; Iwase H Breast Cancer Res; 2003; 5(6):R250-6. PubMed ID: 14580261 [TBL] [Abstract][Full Text] [Related]
2. ATBF1-a messenger RNA expression is correlated with better prognosis in breast cancer. Zhang Z; Yamashita H; Toyama T; Sugiura H; Ando Y; Mita K; Hamaguchi M; Kawaguchi M; Miura Y; Iwase H Clin Cancer Res; 2005 Jan; 11(1):193-8. PubMed ID: 15671546 [TBL] [Abstract][Full Text] [Related]
3. HDAC6 expression is correlated with better survival in breast cancer. Zhang Z; Yamashita H; Toyama T; Sugiura H; Omoto Y; Ando Y; Mita K; Hamaguchi M; Hayashi S; Iwase H Clin Cancer Res; 2004 Oct; 10(20):6962-8. PubMed ID: 15501975 [TBL] [Abstract][Full Text] [Related]
4. Quantitation of HDAC1 mRNA expression in invasive carcinoma of the breast*. Zhang Z; Yamashita H; Toyama T; Sugiura H; Ando Y; Mita K; Hamaguchi M; Hara Y; Kobayashi S; Iwase H Breast Cancer Res Treat; 2005 Nov; 94(1):11-6. PubMed ID: 16172792 [TBL] [Abstract][Full Text] [Related]
5. The role of aromatase and 17-beta-hydroxysteroid dehydrogenase type 1 mRNA expression in predicting the clinical outcome of human breast cancer. Salhab M; Reed MJ; Al Sarakbi W; Jiang WG; Mokbel K Breast Cancer Res Treat; 2006 Sep; 99(2):155-62. PubMed ID: 16541304 [TBL] [Abstract][Full Text] [Related]
6. Reduced expression of the breast cancer metastasis suppressor 1 mRNA is correlated with poor progress in breast cancer. Zhang Z; Yamashita H; Toyama T; Yamamoto Y; Kawasoe T; Iwase H Clin Cancer Res; 2006 Nov; 12(21):6410-4. PubMed ID: 17085653 [TBL] [Abstract][Full Text] [Related]
7. Quantitative analysis of estrogen receptor-alpha and -beta messenger RNA expression in breast carcinoma by real-time polymerase chain reaction. Iwao K; Miyoshi Y; Egawa C; Ikeda N; Tsukamoto F; Noguchi S Cancer; 2000 Oct; 89(8):1732-8. PubMed ID: 11042568 [TBL] [Abstract][Full Text] [Related]
8. WWOX--the FRA16D cancer gene: expression correlation with breast cancer progression and prognosis. Płuciennik E; Kusińska R; Potemski P; Kubiak R; Kordek R; Bednarek AK Eur J Surg Oncol; 2006 Mar; 32(2):153-7. PubMed ID: 16360296 [TBL] [Abstract][Full Text] [Related]
9. Aromatase localization in human breast cancer tissues: possible interactions between intratumoral stromal and parenchymal cells. Miki Y; Suzuki T; Tazawa C; Yamaguchi Y; Kitada K; Honma S; Moriya T; Hirakawa H; Evans DB; Hayashi S; Ohuchi N; Sasano H Cancer Res; 2007 Apr; 67(8):3945-54. PubMed ID: 17440110 [TBL] [Abstract][Full Text] [Related]
10. Gene expression of estrogen receptor, progesterone receptor and microtubule-associated protein Tau in high-risk early breast cancer: a quest for molecular predictors of treatment benefit in the context of a Hellenic Cooperative Oncology Group trial. Pentheroudakis G; Kalogeras KT; Wirtz RM; Grimani I; Zografos G; Gogas H; Stropp U; Pectasides D; Skarlos D; Hennig G; Samantas E; Bafaloukos D; Papakostas P; Kalofonos HP; Pavlidis N; Fountzilas G Breast Cancer Res Treat; 2009 Jul; 116(1):131-43. PubMed ID: 18668363 [TBL] [Abstract][Full Text] [Related]
11. Quantitative analysis of aromatase, sulfatase and 17beta-HSD(1) mRNA expression in soft tissue metastases of breast cancer. Irahara N; Miyoshi Y; Taguchi T; Tamaki Y; Noguchi S Cancer Lett; 2006 Nov; 243(1):23-31. PubMed ID: 16556483 [TBL] [Abstract][Full Text] [Related]
12. Expression analysis of estrogen receptor alpha coregulators in breast carcinoma: evidence that NCOR1 expression is predictive of the response to tamoxifen. Girault I; Lerebours F; Amarir S; Tozlu S; Tubiana-Hulin M; Lidereau R; Bièche I Clin Cancer Res; 2003 Apr; 9(4):1259-66. PubMed ID: 12684393 [TBL] [Abstract][Full Text] [Related]
13. NCOR1 mRNA is an independent prognostic factor for breast cancer. Zhang Z; Yamashita H; Toyama T; Sugiura H; Ando Y; Mita K; Hamaguchi M; Hara Y; Kobayashi S; Iwase H Cancer Lett; 2006 Jun; 237(1):123-9. PubMed ID: 16019133 [TBL] [Abstract][Full Text] [Related]
14. Prognostic role of a multigene reverse transcriptase-PCR assay in patients with node-negative breast cancer not receiving adjuvant systemic therapy. Esteva FJ; Sahin AA; Cristofanilli M; Coombes K; Lee SJ; Baker J; Cronin M; Walker M; Watson D; Shak S; Hortobagyi GN Clin Cancer Res; 2005 May; 11(9):3315-9. PubMed ID: 15867229 [TBL] [Abstract][Full Text] [Related]
15. Levels of hypoxia-inducible factor-1alpha independently predict prognosis in patients with lymph node negative breast carcinoma. Bos R; van der Groep P; Greijer AE; Shvarts A; Meijer S; Pinedo HM; Semenza GL; van Diest PJ; van der Wall E Cancer; 2003 Mar; 97(6):1573-81. PubMed ID: 12627523 [TBL] [Abstract][Full Text] [Related]
16. Expression of HER2 and the coamplified genes GRB7 and MLN64 in human breast cancer: quantitative real-time reverse transcription-PCR as a diagnostic alternative to immunohistochemistry and fluorescence in situ hybridization. Vinatzer U; Dampier B; Streubel B; Pacher M; Seewald MJ; Stratowa C; Kaserer K; Schreiber M Clin Cancer Res; 2005 Dec; 11(23):8348-57. PubMed ID: 16322295 [TBL] [Abstract][Full Text] [Related]
17. High survivin mRNA expression is a predictor of poor prognosis in breast cancer: a comparative study at the mRNA and protein level. Xu C; Yamamoto-Ibusuki M; Yamamoto Y; Yamamoto S; Fujiwara S; Murakami K; Okumura Y; Yamaguchi L; Fujiki Y; Iwase H Breast Cancer; 2014 Jul; 21(4):482-90. PubMed ID: 22968628 [TBL] [Abstract][Full Text] [Related]
18. High MMP-1 mRNA expression is a risk factor for disease-free and overall survivals in patients with invasive breast carcinoma. Cheng S; Tada M; Hida Y; Asano T; Kuramae T; Takemoto N; Hamada J; Miyamoto M; Hirano S; Kondo S; Moriuchi T J Surg Res; 2008 May; 146(1):104-9. PubMed ID: 17663001 [TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of insulin-like growth factor binding protein (IGFBP)-4 and IGFBP-5 expression in breast cancer. Mita K; Zhang Z; Ando Y; Toyama T; Hamaguchi M; Kobayashi S; Hayashi S; Fujii Y; Iwase H; Yamashita H Jpn J Clin Oncol; 2007 Aug; 37(8):575-82. PubMed ID: 17675285 [TBL] [Abstract][Full Text] [Related]
20. In situ levels of oestrogen producing enzymes and its prognostic significance in postmenopausal breast cancer patients. Licznerska BE; Wegman PP; Nordenskjöld B; Wingren S Breast Cancer Res Treat; 2008 Nov; 112(1):15-23. PubMed ID: 18030614 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]